Concentra Group Holdings Parent, Inc. announced its financial results for the second quarter ended June 30, 2025. Revenue increased 15.2% to $550.8 million, compared to $477.9 million in the prior-year quarter. Income from operations grew 6.7% to $89.5 million, while net income decreased to $46.2 million, or $0.35 per basic and diluted share, primarily due to higher interest expense from the IPO recapitalization.
Adjusted EBITDA increased 13.2% to $115.0 million. The company provided updates on its acquisition strategy, confirming the Pivot Onsite Innovations acquisition closed on June 1, 2025, for $54.4 million, adding over 240 onsite health clinics and expanding its total onsite footprint to over 400 locations.
Concentra raised its financial guidance for full-year 2025, now expecting revenue between $2,175 million and $2,225 million and Adjusted EBITDA between $430 million and $445 million. The company also declared a cash dividend of $0.0625 per share, payable on August 28, 2025, to stockholders of record as of August 21, 2025. The net leverage ratio as of June 30, 2025, was 3.8x, with a target of 3.5x by the end of 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.